Aerovate Therapeutics

About:

Aerovate Therapeutics is a biotechnology company focused on developing drugs for rare cardiopulmonary disease.

Website: https://www.aerovatetx.com/

Top Investors: RA Capital Management, Cormorant Asset Management, Sofinnova Investments, Atlas Venture, Surveyor Capital

Description:

Aerovate Therapeutics is a biotechnology company focused on developing drugs that meaningfully improve the lives of patients with rare cardiopulmonary disease. Aerovate's program is a potentially disease-modifying drug, AV-101, for people who suffer from pulmonary arterial hypertension (PAH). AV-101 is a proprietary inhaled dry powder formulation of the drug imatinib that delivers this medicine directly to diseased lung tissues while reducing systemic adverse side effects.